Improving asthma symptom control in rural communities: The design of the Better Respiratory Education and Asthma Treatment in Hinton and Edson study

Controlled Clinical Trials

Volumn 25, Issue 5, 2004, Pages 502-514

  Charrois, Theresa ^a   Newman, Stephen ^a   Sin, Don ^a   Senthilselvan, Ambikaipakan ^a   Tsuyuki, Ross T ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Asthma; Delivery of health care; Outcomes research; Patient education; Pharmacists; Study design

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; STEROID;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CLINICAL TRIAL; COMMUNITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CONTROL; DRUG UTILIZATION; EMERGENCY WARD; FORCED EXPIRATORY VOLUME; GENERAL PRACTITIONER; HEALTH EDUCATION; HEALTH PRACTITIONER; HEALTH PROGRAM; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; MEASUREMENT; MEDICAL INFORMATION; METHODOLOGY; PATIENT CARE; PATIENT EDUCATION; PATIENT REFERRAL; PHARMACIST; PHARMACY; POPULATION; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RURAL AREA; SYMPTOM;

ADOLESCENT; ADULT; ASTHMA; DELIVERY OF HEALTH CARE; FEMALE; HEALTH EDUCATION; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RESPIRATION; RURAL POPULATION;

EID: 4644258071     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cct.2004.07.004     Document Type: Article

References (41)

1. R. Beasley The burden of asthma with specific reference to the United States J. Allergy Clin. Immunol. 109 2002 S482 S489
2. A. Senthilselvan Prevalence of physician-diagnosed asthma in Saskatchewan, 1981 to 1990 Chest 114 1998 388 392
3. P. Burney The changing prevalence of asthma? Thorax 57 Suppl. 2 2002 ii36 ii39
4. R. Beasley, J. Crane, C.K.W. Lai, and N. Pearce Prevalence and etiology of asthma J. Allergy Clin. Immunol. 105 2000 S466 S472
5. S.L. Johnston, and S.T. Holgate Asthma: critical debates 2002 Blackwell Science London
6. K.B. Weiss, S.D. Sullivan, and C.S. Lyttle Trends in the cost of illness for asthma in the United States, 1985â€"1994 J. Allergy Clin. Immunol. 106 2000 493 499
7. E.S. Ford, D.M. Mannino, and D.M. Homa Self-reported asthma and health-related quality of life: findings from the behavioural risk factor surveillance system Chest 123 2003 119 127
8. D.D. Sin, S.F.P. Man, R.L. Cowie for the ASTHMA Executive Committee Asthma practice of family physicians and walk-in-clinics (abstract) Am. J. Respir. Crit. Care Med. 165 2002 A564
9. N. Yuksel, S. Ginther, P. Man, and R.T. Tsuyuki Underuse of inhaled corticosteroids in adults with asthma Pharmacotherapy 20 2000 387 393
10. L.-P. Boulet, A. Becker, D. Berube, R. Beveridge, and P. Ernst Canadian asthma consensus report, 1999 CMAJ 161 1999 S1 S61
11. A.P. Legorreta, J. Christian-Herman, R.D. O'Connor, M.M. Hasan, R. Evans, and K.-M. Leung Compliance with national asthma management guidelines and specialty care: a health maintenance organization experience Arch. Intern. Med. 158 1998 457 464
12. D.D. Sin, and J.V. Tu Underuse of inhaled steroid therapy in elderly patients with asthma Chest 119 2001 720 725
13. D.D. Sin, and S.F. Man Low dose inhaled corticosteroid therapy and risk of emergency department visits for asthma Arch. Intern. Med. 162 2002 1591 1595
14. S. Suissa, P. Ernst, and A. Kezouh Regular use of inhaled corticosteroids and the long-term prevention of hospitalisation for asthma Thorax 57 2002 880 884
15. S.F. Lanes, L.A. Garcia-Rodriguez, and C. Huerta Respiratory medications and risk of asthma death Thorax 57 2002 683 686
16. P.G. Gibson, H. Powell, and J. Coughlan Self-management education and regular practitioner review for adults with asthma Cochrane Database Syst. Rev. 2002 2
17. R.J. Adams, B.J. Smith, and R.E. Ruffin Factors associated with hospital admissions and repeat emergency department visits for adults with asthma Thorax 55 2000 566 573
18. P.G. Gibson Monitoring the patient with asthma: an evidence-based approach J. Allergy Clin. Immunol. 106 2000 17 26
19. L.L. Wolfenden, G.B. Diette, J.A. Krishnan, E.A. Skinner, D.M. Steinwachs, and A.W. Wu Lower physician estimate of underlying asthma severity leads to undertreatment Arch. Intern. Med. 163 2003 231 236
20. K.F. Rabe, P.A. Vermeire, J.B. Soriano, and W.C. Maier Clinical management of asthma in 1999: the asthma insights and reality in Europe (AIRE) study Eur. Respir. J. 16 2000 802 807
21. K.R. Chapman, P. Ernst, A. Grenville, P. Dewland, and S. Zimmerman Control of asthma in Canada: failure to achieve guideline targets Can. Respir. J. 8 Suppl. A 2001 35A 40A
22. S.M. Sawyer, and H.J. Fardy Bridging the gap between doctors' and patients' expectations of asthma management J. Asthma 40 2003 131 138
23. B.P. Nguyen, S.R. Wilson, and D.F. German Patients' perceptions compared with objective ratings of asthma severity Ann. Allergy Asthma Immunol. 77 1996 209 215
24. L.D. Ried, F. Wang, H. Young, and R. Awiphan Patients' satisfaction and their perception of the pharmacist J. Am. Pharm. Assoc. (Wash.) 39 1999 835 842
25. D.L. Knoell, J.F. Pierson, C.B. Marsh, J.N. Allen, and D.S. Pathak Measurement of outcomes in adults receiving pharmaceutical care in a comprehensive asthma outpatient clinic Pharmacotherapy 18 1998 1365 1374
26. J.W. Stout, L.C. White, and L.T. Rogers The asthma outreach program: a promising approach to comprehensive asthma management J. Asthma 35 1998 119 127
27. T.H. Self, J.B. Brooks, P. Lieberman, and M.R. Ryan The value of demonstration and role of the pharmacist in teaching correct use of pressurized bronchodilators CMAJ 128 1983 129 131
28. W.P. Munroe, K. Kunz, C. Dalmady-Israel, L. Potter, and W.H. Schonfeld Economic evaluation of pharmacist involvement in disease management in a community pharmacy setting Clin. Ther. 19 1997 113 123
29. C.D. Mullins, R. Baldwin, and E.M. Perfetto What are outcomes? J. Am. Pharm. Assoc. (Wash.) NS36 1996 39 49
30. M. Weinberger, M.D. Murray, and D.G. Marrero Effectiveness of pharmacist care for patients with reactive airways disease: a randomized controlled trial JAMA 288 2002 1594 1602
31. R.T. Guidry Pharmacist care for reactive airway disease (letter) JAMA 289 2003 1103 1104
32. J. Jameson, and A.J. Plas Pharmacist care for reactive airway disease (letter) JAMA 289 2003 1104
33. M. Schulz Pharmacist care for reactive airway disease (letter) JAMA 289 2003 1104
34. A.K. Ghosh Pharmacist care for reactive airway disease (letter) JAMA 289 2003 1104
35. J.A. Gans, and J.M. Williams Pharmacist care for reactive airway disease (letter) JAMA 289 2003 1105
36. W. McLean, J. Gillis, and R. Waller The BC Community Pharmacy Asthma Study: a study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia Can. Respir. J. 10 2003 195 202
37. E.F. Juniper, P.M. O'Byrne, G.H. Guyatt, P.J. Ferrie, and D.R. King Development and validation of a questionnaire to measure asthma control Eur. Respir. J. 14 1999 902 907
38. L. Dolovich, K. Agro, and M. Sabharwal The asthma community pharmacist training trial (ACTT) [Abstract] Chest 118 2000 137S
39. Y. Chen, R. Dales, and D. Krewski Asthma and the risk of hospitalization in Canada: the role of socioeconomic and demographic factors Chest 119 2001 708 713
40. A.H. Anis, L.D. Lynd, and X.-H. Wang Double trouble: impact of inappropriate use of asthma medication on the use of health care resources CMAJ 164 2001 625 631
41. A.L. Fuhlbrigge, R.J. Adams, and T.W. Guilbert The burden of asthma in the United States: level and distribution are dependent on interpretation of the national asthma education and prevention program guidelines Am. J. Respir. Crit. Care Med. 166 2002 1044 1049